[Gabapentin in the treatment of polyneuropathy associated with the human immunodeficiency virus].
Peña
D
D
Prada
J L
JL
de La Torre
J
J
del Arco
A
A
García-Alegría
J
J
D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018755:GABA Agonists / Q000627:therapeutic use*; D000077206:Gabapentin; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D008297:Male; D011115:Polyneuropathies / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018755:GABA Agonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin